These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7538000)

  • 1. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children.
    Leibundgut K; von Rohr A; Brülhart K; Hirt A; Ischi E; Jeanneret C; Muff J; Ridolfi-Lüthy A; Wagner HP; Tobler A
    Bone Marrow Transplant; 1995 Jan; 15(1):25-31. PubMed ID: 7538000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
    Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
    Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients.
    Engel BC; Laws HJ; Dirksen U; Kramm CM; Göbel U; Burdach SE
    Klin Padiatr; 1997; 209(4):186-90. PubMed ID: 9293449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood.
    Sawant RB; Rajadhyaksha SB
    J Assoc Physicians India; 2005 Dec; 53():1031-5. PubMed ID: 16572958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New method for stem cell quantification: applications to the management of peripheral blood stem cell transplantation.
    Legros M; Fleury J; Curé H; Condat P; Lenat A; Subtil E; Sanderson D; Communal Y; Basile M; Tavernier F
    Bone Marrow Transplant; 1995 Jan; 15(1):1-8. PubMed ID: 7537997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model.
    Hillyer CD; Swenson RB; Hart KK; Lackey DA; Winton EF
    Exp Hematol; 1993 Oct; 21(11):1455-9. PubMed ID: 8405225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF.
    Mitterer M; Hirber J; Gentilini I; Prinoth O; Fabris P; Emmerich B; Coser P; Straka C
    Bone Marrow Transplant; 1996 Sep; 18(3):611-7. PubMed ID: 8879626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.